Showing results (61-70 of 506) with videos related to
Sort By:
Pageof 51
Thrombosis Research|June 12, 2012
Splanchnic vein thrombosis: new risk factors and managementMarco P Donadini, Francesco Dentali, Walter AgenoThrombosis and Haemostasis|June 9, 2017
Venous thromboembolism: Past, present and futureSam Schulman, Walter Ageno, Stavros V KonstantinidesExpert Review of Cardiovascular Therapy|September 16, 2020
Rivaroxaban for the treatment of venous thromboembolism in pediatric patientsOmri Cohen, Sarina Levy-Mendelovich, Walter AgenoExpert Opinion on Pharmacotherapy|August 9, 2017
Once- versus twice-daily direct oral anticoagulants in non-valvular atrial fibrillationWalter Ageno, Jan Beyer-Westendorf, Andrea RubboliHematology. American Society of Hematology. Education Program|February 20, 2015
Management of incidental splanchnic vein thrombosis in cancer patientsLisa Baumann Kreuziger, Walter Ageno, Agnes LeeExpert Opinion on Investigational Drugs|April 29, 2022
Investigational drugs for ischemic stroke: what's in the clinical development pipeline for acute phase and prevention?Maria Giulia Mosconi, Maurizio Paciaroni, Walter AgenoExpert Opinion on Pharmacotherapy|November 26, 2015
Treating patients with cancer and acute venous thromboembolismMarco P Donadini, Alessandro Squizzato, Walter AgenoThrombosis and Haemostasis|December 5, 2014
Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammationNicoletta Riva, Marco P Donadini, Walter AgenoExpert Review of Cardiovascular Therapy|August 4, 2011
Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-extension study)Erica Romualdi, Marco P Donadini, Walter AgenoExpert Review of Hematology|February 23, 2023
Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosisLucia M Caiano, Nicoletta Riva, Walter AgenoPageof 51